Association of plasma biomarkers with longitudinal change in age- and Alzheimer's disease-related brain atrophy patterns
In cognitively unimpaired individuals from the Baltimore Longitudinal Study of Aging, plasma p-tau217 demonstrated the strongest association with both subsequent Alzheimer's disease-related dementia and longitudinal changes in AD-specific brain atrophy patterns compared to other plasma biomarkers.